{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:49Z","timestamp":1786984189066,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1301203"],"award-info":[{"award-number":["2016YFC1301203"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ahj.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T01:20:19Z","timestamp":1636852819000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial"],"prefix":"10.1016","volume":"244","author":[{"given":"Dong","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8765-4941","authenticated-orcid":false,"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.11.005_bib0001","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC working group on coronary pathophysiology and microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease","volume":"116","author":"Padro","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2021.11.005_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.11.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004373","article-title":"Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?","volume":"10","author":"Bulluck","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2021.11.005_bib0004","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0195-668X(03)00318-X","article-title":"Nicorandil: a drug for many purposes: too good to be true?","volume":"24","author":"Eeckhout","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.11.005_bib0005","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.104.530329","article-title":"Impact of a single intravenous administration of nicorandil before reperfusion in patients with st-segment-elevation myocardial infarction","volume":"112","author":"Ishii","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.11.005_bib0006","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehp077","article-title":"Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon","volume":"30","author":"Kawai","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.11.005_bib0007","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1253\/circj.CJ-11-1110","article-title":"Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome","volume":"76","author":"Ishihara","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2021.11.005_bib0008","doi-asserted-by":"crossref","first-page":"e78231","DOI":"10.1371\/journal.pone.0078231","article-title":"Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2021.11.005_bib0009","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","article-title":"J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials","volume":"370","author":"Kitakaze","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2021.11.005_bib0010","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.11.005_bib0011","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol 2018"},{"key":"10.1016\/j.ahj.2021.11.005_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2019.105259","article-title":"Computational issues in fitting joint frailty models for recurrent events with an associated terminal event","volume":"188","author":"Toenges","year":"2020","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.ahj.2021.11.005_bib0013","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00380-015-0752-3","article-title":"Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging","volume":"31","author":"Yamada","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ahj.2021.11.005_bib0014","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0735-1097(98)00604-4","article-title":"Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction","volume":"33","author":"Ito","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.11.005_bib0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0735-1097(00)01171-2","article-title":"Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin","volume":"37","author":"Okamura","year":"2001","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321004488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321004488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:08:07Z","timestamp":1757570887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321004488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":15,"alternative-id":["S0002870321004488"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.11.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}